TuesdayNov 16, 2021 3:02 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Working on Answer to Mass Production of Rare, Otherwise Depleted Cannabinoid Opportunities

InMed Pharmaceuticals (NASDAQ: INM) and its subsidiary BayMedica are innovators in the field of rare cannabinoids, making them available for consumer access. InMed specializes in developing a proprietary biosynthesis system to manufacture pharmaceutical-grade cannabinoids that are otherwise too rare to be acquired in abundance. Through BayMedica, its recent acquisition, InMed also has capabilities in both yeast biosynthesis and chemical synthesis, catering to the large and growing health and wellness consumer markets. “The cannabis plant is made up of over 100 unique cannabinoids, many of which are only found in trace amounts,” reads a recent article. “With so many of these…

Continue Reading

TuesdayNov 16, 2021 2:32 pm

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Names New Chief Marketing Officer

GreenBox (NASDAQ: GBOX), an emerging fintech company leveraging proprietary blockchain security and token technology to build customized payment solutions, has appointed Jacqueline B. Reynolds as the company’s new chief marketing officer. In her new role, Reynolds will lead all marketing strategy, including the development of GreenBox’s brand positioning and communications plan. Reynolds served most recently as vice president of marketing for Sprouts Farmers Market, and she brings decades of experience with some of the world’s most coveted brands. She has built a reputation as a world-class global marketer, working with Coca-Cola, McDonalds, Verizon, Walmart, L’Oreal, Xbox, 7-Eleven and many other Fortune…

Continue Reading

TuesdayNov 16, 2021 2:25 pm

QualityStocksNewsBreaks – Numinus Wellness Inc. (TSX.V: NUMI) Advances MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials

Numinus Wellness (TSX.V: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, recently announced that it has secured two new Canadian psychedelic clinics to host the Canadian sites of the MAPS Public Benefit Corporation (MAPS PBC) study “A multi-site open-label extension study of MDMA-assisted psychotherapy for PTSD (MAPPUSX).” Per the release, the two new clinics are fully compliant with Health Canada regulations and ready to provide MDMA-assisted therapy as part of the trial. The Montreal and Vancouver sites, hosted by Numinus, will continue to advance the study of the safety and efficacy of MDMA in treating severe PTSD, under…

Continue Reading

TuesdayNov 16, 2021 2:18 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at Upcoming Virtual Investor Roundtable

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be presenting at the Virtual Investor Roundtable Event, scheduled for Nov. 18, 2021. The CNSP overview, presented by CNS Pharmaceuticals CEO John Climaco and chief medical officer Sandra L. Silberman, MD, PhD. will begin at 9 a.m. ET. The presentation will be followed by a moderated roundtable discussion with time also included for questions and answers, which may be submitted by investors and interested parties during the live event. Questions may also be submitted…

Continue Reading

TuesdayNov 16, 2021 12:44 pm

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) CEO Featured in Latest Episode of ‘Bell2Bell’ Podcast

Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform committed to bringing science-backed benefits to all and reframing the psychedelic conversation, was featured in the latest episode of The Bell2Bell Podcast. Among other highlights of the interview, Delic CEO Matt Stang discussed the company’s network of businesses and the impact psychedelic research is having on the treatment of mental health. “We feel that the time is right now. The mental health crisis is sweeping not only this country but the world,” Delic Holdings CEO Matt Stang stated in the interview. “Last year, in America, we had four-times the…

Continue Reading

TuesdayNov 16, 2021 11:29 am

QualityStocksNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FRA: E4X2) Releases Q3 2021 Financial Report

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FRA: E4X2) has reported its financial results for the three- and nine-month periods ended Sept. 30, 2021. Highlights of the report include revenues of $9.2 million with gross profit of $1.8 million and total cash cost net of byproducts per silver ounce payable improved to $11.02. The company noted that all-in sustaining cost ("AISC") per silver ounce payable totaled $21.52, in part due to increased underground exploration at Platosa, with production cost of $281 per ton. Excellon also saw more than 21,000 tons mined and milled for the fifth quarter in a row, with sizeable stockpiles of ore and…

Continue Reading

TuesdayNov 16, 2021 11:08 am

QualityStocksNewsBreaks – Lottery.com (NASDAQ: LTRY) Releases Q3, Year-to-Date Numbers, Business Highlights

Lottery.com (NASDAQ: LTRY, LTRYW), a leading technology company that is transforming how, where and when the lottery is played, has reported its Q3 2021 numbers for the period ended Sept. 30, 2021. Highlights of the report include third-quarter revenue reaching $32.2 million with a net income of $11.2 million; the company noted that the growth was driven by itsglobal affiliate marketing program. Gross profit for the period totaled  $20.3 million, an increase of $19.4 million from Q3 2020, with third-quarter 2021 net income reaching $11.2 million, compared to a net loss of $1.2 million for the same period last year.…

Continue Reading

TuesdayNov 16, 2021 10:40 am

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q3 2021 Financial, Operational Report

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (“OSA”) and snoring in adults, has released is third-quarter 2021 financial report; the company also reported on operational highlights. The report noted that VVOS Q3 revenue increase more than 38% year over year, reaching $4.5 million for the third quarter of 2021 and $12.5 million for the nine months ended Sept. 30, 2021 as compared to $3.3 million and $9.8 million for the three and nine months for the same period last…

Continue Reading

TuesdayNov 16, 2021 10:23 am

QualityStocksNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Reports Q3 Financial Numbers, Business Highlights

AmpliTech Group (NASDAQ: AMPG), a designer, developer and manufacturer of state-of-the-art, signal-processing components for satellite and 5G communications networks, defense, space and other commercial applications, has released its Q3 2021 financial results as well as results for its  first nine months of 2021. Third-quarter revenue totaled $1,056,595 for the quarter with the company contracting for $1.2 million in new orders for LNA technology in the fourth quarter, resulting in AmpliTech increasing its order backlog to a record $3.35 million as of Nov. 15, 2021, compared to a $2.45 million backlog in August 2021. The company also signed a lease for…

Continue Reading

MondayNov 15, 2021 2:09 pm

QualityStocksNewsBreaks – Tingo Inc. (IWBB) Reports Q3 Results

Tingo (OTC: IWBB), a leading agri-fintech business in Africa, has released its unaudited financial results for the three and nine months ended September 30, 2021. Worth noting is that, on a proforma basis, IWBB’s wholly owned subsidiary, Tingo Mobile PLC, totaled revenues of $177 million and $317.5 million and operating income of $82 million and $170.2 million for the three and nine month periods, respectively. In addition, the report noted that as a percentage of overall revenue, income generated from Tingo’s NWASSA marketplace platform reached $56.5 million and $120.7 million for the three and nine months ended September 30, 2021; both figures…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered